Argatroban Combined With Antiplatelet Versus Antiplatelet for Acute Ischemic Stroke

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 25, 2017

Primary Completion Date

October 8, 2018

Study Completion Date

January 8, 2019

Conditions
Stroke, Ischemic
Interventions
DRUG

Argatroban plus dual antiplatelet

A continuous argatroban infusion of 1.0 ug/kg per minute for 2-5 days adjusted to a target activated partial thromboplastin time of 1.75 X baseline (about 10%). For the first day, clopidogrel with loading dose 300mg, and aspirin 100mg were given, and followed by clopidogrel 75 mg and aspirin 100mg each day

Trial Locations (1)

10016

General Hospital of Shenyang Military Region, Shenyang

All Listed Sponsors
lead

General Hospital of Shenyang Military Region

OTHER

NCT03552354 - Argatroban Combined With Antiplatelet Versus Antiplatelet for Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter